Spring 2010 Meeting: Edinburgh International Conference Centre, Edinburgh - 29 March - 1 April 2010

(ED20) The global challenges of virus infection
Thursday 1 April 2010
Organizers: Martin Cranage, Paul Duprex — email p.duprex@qub.ac.uk & Katie Jeffery
Provisional Programme
Viruses "respect" neither geographical nor political borders. Currently this is best exemplified by the swine flu pandemic which has critically thrown the spotlight onto the interconnectivity that exists across the globe. This symposium recognizes the global dimension of virus infection, both in the developed and the developing world. The scene will be set by David Heymann (Chair of the Health Protection Agency) who will provide a unique insight into global virology based on an international career at the cutting edge of public health. This will be augmented by state of the art lectures focusing on HIV, influenza, hepatitis C virus, rotavirus, Dengue and measles virus.
Chair: Paul Duprex (Queen's University of Belfast)
0830 David Heymann Health Protection Agency, London Global challenges in virus infection
0910 Malik Peiris University of Hong Kong

Influenza: expecting the unexpected

0950 Neil Ferguson Imperial College London The H1N1 influenza pandemic: transmission dynamics, impact and public health response
1030 Refreshments
Chair: Katie Jeffery (John Radcliffe Hospital, Oxford)
1100 Roger Glass Fogarty International Center, National Institutes of Health, Bethesda, USA Rotavirus and other enteric viruses
1140 Diane E. Griffin The Johns Hopkins Bloomberg School of Public Health, Baltimore, USA Measles: pathogenesis and control
1220 Jeremy Farrar Hospital for Tropical Diseases, South East Asia Infectious Disease Clinical Research Network, Viet Nam Dengue
1300 Lunch
Chair: Martin Cranage (St George's, University of London)
1330 Stephen Livingston Alaska Native Tribal Health Consortium, USA Hepatitis C: present and future
1410 Robin Shattock St George's University of London HIV
1450 Dan H. Barouch Beth Israel Deaconess Medical Center, Boston, USA

Novel vectors and antigens for a next generation HIV-1 vaccine

1530 End of symposium

Last updated Friday 29 January 2010